 Connection
Udaya Kompella to In Vitro Techniques
This is a "connection" page, showing publications Udaya Kompella has written about In Vitro Techniques.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.223 |
|
|
|
-
Ayalasomayajula SP, Amrite AC, Kompella UB. Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas. Eur J Pharmacol. 2004 Sep 13; 498(1-3):275-8.
Score: 0.051
-
Koushik KN, Kompella UB. Transport of deslorelin, an LHRH agonist, is vectorial and exhibits regional variation in excised bovine nasal tissue. J Pharm Pharmacol. 2004 Jul; 56(7):861-8.
Score: 0.051
-
Kompella UB, Sunkara G, Thomas E, Clark CR, Deruiter J. Rabbit corneal and conjunctival permeability of the novel aldose reductase inhibitors: N-[[4-(benzoylamino)phenyl] sulphonyl]glycines and N-benzoyl-N-phenylglycines. J Pharm Pharmacol. 1999 Aug; 51(8):921-7.
Score: 0.036
-
Dani BA, Kompella UB. Inhibition of corneal metabolism of deslorelin by EDTA and ZnCl2. Drug Dev Ind Pharm. 1998 Jan; 24(1):11-7.
Score: 0.032
-
Kompella UB, Dani BA. Metabolism of [des-Gly10, D-Trp6]LHRH ethylamide in the rabbit conjunctiva. J Ocul Pharmacol Ther. 1997 Apr; 13(2):163-70.
Score: 0.031
-
Tewari-Singh N, Jain AK, Inturi S, Ammar DA, Agarwal C, Tyagi P, Kompella UB, Enzenauer RW, Petrash JM, Agarwal R. Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries. Toxicol Appl Pharmacol. 2012 Oct 01; 264(1):23-31.
Score: 0.022
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|